Pharmacokinetic Changes of Psychotropic Drugs in Patients with Liver Disease: Implications for Dose Adaptation

By Schlatter Chantal   Egger Sabin S.   Tchambaz Lydia   Krähenbühl Stephan  

Drug Safety, Vol. 32, Iss. 7, 2009-07 ,pp. : 561-578

Adis International

Access to resources Recommend Favorite

Dose Adjustment in Patients with Liver Disease

By Delcò Fabiola   Tchambaz Lydia   Schlienger Raymond   Drewe Jürgen   Krähenbühl Stephan  

Drug Safety, Vol. 28, Iss. 6, 2005-01 ,pp. : 529-545

Adis International

Access to resources Recommend Favorite

Dose adjustment of drugs with high hepatic extraction are required in patients with severe liver disease

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 5, 2006-05 ,pp. : 23-26

Adis International

Access to resources Recommend Favorite

Emerging drugs for complications of end-stage liver disease

By Dowman Joanna K   Holt Andrew P   Newsome Philip N   Adams David H  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 159-174

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for non-alcoholic fatty liver disease

By Federico Alessandro   Niosi Marco   Vecchio Blanco Camillo Del   Loguercio Carmela  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 145-158

Informa Healthcare

Access to resources Recommend Favorite